Consensus EPS · Q2 2026
$3.69
Consensus revenue · Q2 2026
$1.6B
Analysts
6
Expected report
Jul 22, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 6 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.6B | $1.6B | $1.6B |
| EPS | $3.65 | $3.69 | $3.75 |
| EBITDA | $394.6M | $397.1M | $399.6M |
| EBIT | $394.6M | $397.1M | $399.6M |
| Net income | $291.7M | $293.3M | $297.3M |
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Globe Life (GL) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
| Low | Consensus | Median | High | Current | Upside |
|---|---|---|---|---|---|
| $157.00 | $174.50 | $178.00 | $185.00 | $178.86 | -2.4% |
Upside calculated vs most recent trading price of $178.86.
Analyst ratings
Consensus: Hold — based on 28 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 23, 2026 | TD Cowen | maintain | Buy | Buy |
| May 26, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| May 21, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Apr 24, 2026 | Truist Securities | maintain | Buy | Buy |
| Apr 10, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Feb 25, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Feb 18, 2026 | Evercore ISI Group | maintain | In Line | In Line |
| Feb 6, 2026 | Truist Securities | maintain | Buy | Buy |
| Feb 5, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Dec 11, 2025 | TD Cowen | maintain | Buy | Buy |
Frequently asked questions
Globe Life (GL) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation